2016
DOI: 10.1093/europace/euw017
|View full text |Cite
|
Sign up to set email alerts
|

Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study

Abstract: Atrial fibrillation risk discrimination was significantly improved by the addition of PAC to the Framingham AF risk model, but not by the addition of NT-proBNP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 32 publications
0
14
0
Order By: Relevance
“…Second, AF might serve as an intermediary between PACs and CV outcomes. PACs independently predicted incidence of AF and significantly improved the predictive performance of Framingham AF risk model . On the other hand, PACs might be a surrogate of undetected occult paroxysmal AF in patients with stroke .…”
Section: Discussionmentioning
confidence: 89%
“…Second, AF might serve as an intermediary between PACs and CV outcomes. PACs independently predicted incidence of AF and significantly improved the predictive performance of Framingham AF risk model . On the other hand, PACs might be a surrogate of undetected occult paroxysmal AF in patients with stroke .…”
Section: Discussionmentioning
confidence: 89%
“…The FHS-AF (Framingham Heart Study risk score for AF) model had originally been derived for predicting 10-year incident AF risk, but had later been recalibrated and subsequently externally validated for 5-year risk of incident AF. 33 , 40 …”
Section: Resultsmentioning
confidence: 99%
“…All studies used the C-statistic to assess model discrimination for incident AF within their cohorts. Nine studies assessed calibration by providing both a P -value for a goodness-of-fit test and a calibration plot in at least one of the risk models that these studies reported on refs, 20 , 21 , 24 , 27 , 29 , 30 , 32 , 36 , 40 seven studies assessed calibration only by a P -value for goodness-of-fit test, 22 , 26 , 35 , 39 , 41 , 43 , 44 two studies assessed calibration only by a calibration plot, 25 , 33 and nine studies reported neither of these calibration parameters. 23 , 28 , 31 , 34 , 37 , 38 , 42 , 45 , 46 …”
Section: Resultsmentioning
confidence: 99%
“…The first step is to perform a prospective international registry to confirm that IAB is associated with a high risk of AF and stroke in the elderly population with heart disease [ 22 ]. After showing the magnitude of this association, the second step is to perform a randomized control trial to test the benefits of anticoagulation in patients with heart disease, sinus rhythm, and A-IAB [ 23 ], probably adding as inclusion criteria other factor related with AF and stroke as advanced age [ 24 ] and atrial ectopy [ 25 ]. Our hypothesis also opens the door to other drugs, for instance as the renin-angiotensin-aldosterone system inhibition might have a role in the reduction of the risk of developing new onset AF [ 26 ], these medications might improve prognosis of patients with advanced IAB.…”
Section: Should Anticoagulation Be Used In Some Patients With Advancementioning
confidence: 99%